search
Back to results

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON)

Primary Purpose

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease

Status
Recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Placebo
Inhaled Treprostinil
Treprostinil Ultrasonic Nebulizer
Sponsored by
United Therapeutics
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Idiopathic Pulmonary Fibrosis focused on measuring Treprostinil, IPF, ILD

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Subject gives voluntary informed consent to participate in the study.
  2. Subject is ≥40 years of age, inclusive, at the time of signing informed consent.
  3. The subject has a diagnosis of IPF based on the 2018 ATS/ERS/JRS/ALAT Clinical Practice Guideline (Raghu 2018) and confirmed by central review of high-resolution computed tomography (HRCT) (performed within the previous 12 months), and if available, surgical lung biopsy.
  4. FVC ≥45% predicted at Screening.
  5. Subjects on pirfenidone or nintedanib must be on a stable and optimized dose for ≥30 days prior to Baseline. Concomitant use of both pirfenidone and nintedanib is not permitted.
  6. Women of childbearing potential must be non-pregnant (as confirmed by a urine pregnancy test at Screening and Baseline) and non-lactating, and will abstain from intercourse (when it is in line with their preferred and usual lifestyle) or use 2 medically acceptable, highly effective forms of contraception for the duration of the study, and at least 30 days after discontinuing study drug.
  7. Males with a partner of childbearing potential must use a condom for the duration of treatment and for at least 48 hours after discontinuing study drug.
  8. In the opinion of the Investigator, the subject is able to communicate effectively with study personnel, and is considered reliable, willing, and likely to be cooperative with protocol requirements, including attending all study visits.

Exclusion Criteria:

  1. Subject is pregnant or lactating.
  2. Subject has primary obstructive airway physiology: FEV1/FVC <0.70 at Screening.
  3. The subject has shown intolerance or significant lack of efficacy to a prostacyclin or prostacyclin analogue that resulted in discontinuation or inability to effectively titrate that therapy.
  4. The subject has received any PAH-approved therapy, including prostacyclin therapy (epoprostenol, treprostinil, iloprost, or beraprost; except for acute vasoreactivity testing), IP receptor agonists (selexipag), endothelin receptor antagonists, phosphodiesterase type 5 inhibitors (PDE5-Is), or soluble guanylate cyclase stimulators within 60 days prior to Baseline. As needed use of a PDE5-I for erectile dysfunction is permitted, provided no doses are taken within 48 hours of any study-related efficacy assessments.
  5. Use of any of the following medications: azathioprine (AZA), cyclosporine, mycophenolate mofetil, tacrolimus, oral corticosteroids (OCS) >20 mg/day or the combination of OCS+AZA+N-acetylcysteine within 30 days prior to Baseline; cyclophosphamide within 60 days prior to Baseline; or rituximab within 6 months prior to Baseline.
  6. The subject is receiving >10 L/min of oxygen supplementation by any mode of delivery at rest at Baseline.
  7. Exacerbation of IPF or active pulmonary or upper respiratory infection within 30 days prior to Baseline. Subjects must have completed any antibiotic or steroid regimens for treatment of the infection or acute exacerbation more than 30 days prior to Baseline to be eligible. If hospitalized for an acute exacerbation of IPF or a pulmonary or upper respiratory infection, subjects must have been discharged more than 90 days prior to Baseline to be eligible.
  8. Uncontrolled cardiac disease, defined as myocardial infarction within 6 months prior to Baseline or unstable angina within 30 days prior to Baseline.
  9. In the opinion of the Investigator, the subject has any condition that would interfere with the interpretation of study assessments or would impair study participation or cooperation.
  10. Use of any other investigational drug/device or participation in any investigational study in which the subject received a medical intervention (ie, procedure, device, medication/supplement) within 30 days prior to Screening. Subjects participating in non-interventional, observational, or registry studies are eligible.
  11. Life expectancy <6 months due to IPF or a concomitant illness.
  12. Acute pulmonary embolism within 90 days prior to Baseline.

Sites / Locations

  • The University of Alabama at BirminghamRecruiting
  • Jasper Summit Research, LLC
  • Arizona Pulmonary Specialists, Ltd.
  • St. Joseph's Hospital and Medical Center - Norton Thoracic InstituteRecruiting
  • University of ArizonaRecruiting
  • UC San Diego Health
  • David Geffen School of Medicine at UCLARecruiting
  • NewportNativeMD, IncRecruiting
  • University of California, IrvineRecruiting
  • Palmtree Clinical Research, Inc.Recruiting
  • UC Davis Health Medical Center
  • University of California - San FranciscoRecruiting
  • Stanford University Medical CenterRecruiting
  • National Jewish HealthRecruiting
  • Georgetown University HospitalRecruiting
  • St. Francis Sleep Allergy & Lung InstituteRecruiting
  • University of Florida Health at ShandsRecruiting
  • Ascension St. Vincent'sRecruiting
  • University of FloridaRecruiting
  • Mayo Clinic FloridaRecruiting
  • Pulmonary Disease Specialists, PA d/b/a PDS Research
  • Central Florida Pulmonary Group, PARecruiting
  • Advanced Pulmonary Research InstituteRecruiting
  • Coastal Pulmonary & Critical Care PLC
  • University of South Florida HealthRecruiting
  • Cleveland Clinic FloridaRecruiting
  • Piedmont Healthcare AtlantaRecruiting
  • Emory University HospitalRecruiting
  • Northwestern Memorial HospitalRecruiting
  • Rush University Medical Center Outpatient Pulmonary ClinicRecruiting
  • University of Illinois at ChicagoRecruiting
  • Loyola University Medical CenterRecruiting
  • Community Health NetworkRecruiting
  • The University of Kansas Medical CenterRecruiting
  • Norton Pulmonary SpecialistsRecruiting
  • University of LouisvilleRecruiting
  • Louisville Pulmonary Care,PLLCRecruiting
  • LSU Health Sciences Center New OrleansRecruiting
  • Tulane University Medical CenterRecruiting
  • LSU Health Science Center ShreveportRecruiting
  • Johns Hopkins Asthma & Allergy CenterRecruiting
  • Adventist Healthcare White Oak Medical CEnterRecruiting
  • Tufts Medical CenterRecruiting
  • Brigham and Women's HospitalRecruiting
  • University of Michigan Int Med Pulmonary and critical careRecruiting
  • Henry Ford HospitalRecruiting
  • University of MinnesotaRecruiting
  • Mayo ClinicRecruiting
  • University of Mississippi Medical CenterRecruiting
  • The Lung Research CenterRecruiting
  • Saint Luke's Hospital of Kansas CityRecruiting
  • Washington University School of MedicineRecruiting
  • J&L Research, LLC
  • Creighton University Clinical Research OfficeRecruiting
  • University of New Mexico Health Sciences CenterRecruiting
  • Montefiore Medical CenterRecruiting
  • Northwell HealthRecruiting
  • University of Rochester Medical centerRecruiting
  • PulmonIx, LLCRecruiting
  • East Carolina University and Leo Jenkins Cancer CenterRecruiting
  • Pinehurst Medical Clinic, Inc.Recruiting
  • Southeastern Research CenterRecruiting
  • University of CincinnatiRecruiting
  • Cleveland ClinicRecruiting
  • The Ohio State University Wexner Medical Center - Martha Morehouse Medical PavilionRecruiting
  • University of Oklahoma Health Sciences CenterRecruiting
  • The Oregon Clinic, PCRecruiting
  • Penn State Milton S. Hershey Medical Center/Penn State College of MedicineRecruiting
  • University of PennsylvaniaRecruiting
  • Thoams Jefferson,Hospital UniversityRecruiting
  • Temple Lung CenterRecruiting
  • Medical University of South CarolinaRecruiting
  • Prisma Health Midlands
  • Clinical Research of Rock HillRecruiting
  • Clinical Trials Center of Middle TennesseeRecruiting
  • Statecare Pulmonary ConsultantsRecruiting
  • Vanderbilt University Medical CenterRecruiting
  • Baylor University Medical CenterRecruiting
  • Univrsity of Texas Southwestern Medical Center
  • Premier Pulmonary Critical Care and Sleep MedicineRecruiting
  • Baylor Clinic-Baylor College of MedicineRecruiting
  • The University of Texas Health Science Center at HoustonRecruiting
  • A & A Research Consultants, LLC
  • Metroplex Pulmonary and Sleep Center PARecruiting
  • Renovatio Clinical Consultants, LLC
  • Intermountain Medical CenterRecruiting
  • University of Utah HealthRecruiting
  • University of Virginia Health SystemRecruiting
  • Inova Fairfax HospitalRecruiting
  • Pulmonary Associates of Richmond, Inc.Recruiting
  • University of Wisconsin School of Medicine and Public healthRecruiting
  • Medical College of Wisconsin
  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec-UniversiteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Placebo

Inhaled Treprostinil

Arm Description

Matching placebo inhaled using an ultrasonic nebulizer QID

Treprostinil for inhalation solution (0.6 mg/mL) delivered via an ultrasonic nebulizer which emits a dose of approximately 6 mcg per breath. Inhaled QID and titrated up to a target of 12 breaths QID or until the subject reaches their maximum clinically tolerated dose.

Outcomes

Primary Outcome Measures

Change in Absolute FVC from Baseline to Week 52
The FVC measurement indicates the amount of air a person can forcefully and quickly exhale after taking a deep breath.

Secondary Outcome Measures

Time to Clinical Worsening
Clinical worsening was monitored from randomization until 1 of the following criteria were met: death (all causes), hospitalization due to a respiratory indication, or 10% relative decline in % predicted FVC.
Time to First Acute Exacerbation of IPF
An exacerbation of IPF is defined as an acute, clinically significant, respiratory deterioration characterized by evidence of new widespread alveolar abnormality.
Overall Survival at Week 52
Vital status will be assessed for all subjects at Week 52, including those who discontinue the study prematurely or who withdraw consent.
Change in % Predicted FVC from Baseline to Week 52
The FVC measurement indicates the amount of air a person can forcefully and quickly exhale after taking a deep breath. Percent predicted FVC is calculated based on factors such as ethnicity, sex, age, height, and weight.
Change in K-BILD Questionnaire Score from Baseline to Week 52
The K-BILD is a self-administered, 15-item questionnaire validated for patients with interstitial lung disease (ILD) consisting of 3 domains (breathlessness and activities, psychological, and chest symptoms).
Change in DLCO from Baseline to Week 52
The DLCO measurement measures how well oxygen moves from the lungs to the blood.

Full Information

First Posted
January 12, 2021
Last Updated
October 24, 2023
Sponsor
United Therapeutics
search

1. Study Identification

Unique Protocol Identification Number
NCT04708782
Brief Title
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Acronym
TETON
Official Title
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2021 (Actual)
Primary Completion Date
June 2025 (Anticipated)
Study Completion Date
June 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
United Therapeutics

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
Detailed Description
Study RIN-PF-301 is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute FVC in subjects with IPF over a 52-week period. Subjects will be randomly allocated 1:1 to receive inhaled treprostinil or placebo. All subjects will initiate inhaled treprostinil or placebo at a dose of 3 breaths administered 4 times daily (QID) and will titrate to a target dosing regimen of 12 breaths QID. Study drug doses may be titrated up as tolerated, until the target dose or maximum clinically tolerated dose is achieved. Once eligible, 6 Treatment Period visits to the clinic will be required at Weeks 4, 8, 16, 28, 40, and 52. Efficacy assessments include spirometry (FVC), time to clinical worsening, time to first acute exacerbation of IPF, overall survival, King's Brief Interstitial Lung Disease (K-BILD) questionnaire, plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration, supplemental oxygen use, and lung diffusion capacity (DLCO). Safety assessments include the development of adverse events (AEs)/serious adverse events (SAEs), vital signs, clinical laboratory parameters, and electrocardiogram (ECG) parameters. Subjects who complete the Week 52 Visit may be offered the opportunity to enter an open-label extension (OLE) study after completing the final study visit.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Keywords
Treprostinil, IPF, ILD

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
576 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Matching placebo inhaled using an ultrasonic nebulizer QID
Arm Title
Inhaled Treprostinil
Arm Type
Experimental
Arm Description
Treprostinil for inhalation solution (0.6 mg/mL) delivered via an ultrasonic nebulizer which emits a dose of approximately 6 mcg per breath. Inhaled QID and titrated up to a target of 12 breaths QID or until the subject reaches their maximum clinically tolerated dose.
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Placebo administered QID
Intervention Type
Drug
Intervention Name(s)
Inhaled Treprostinil
Other Intervention Name(s)
Tyvaso
Intervention Description
Inhaled treprostinil (6 mcg/breath) administered QID
Intervention Type
Device
Intervention Name(s)
Treprostinil Ultrasonic Nebulizer
Intervention Description
Treprostinil ultrasonic nebulizer which emits a dose of approximately 6 mcg per breath.
Primary Outcome Measure Information:
Title
Change in Absolute FVC from Baseline to Week 52
Description
The FVC measurement indicates the amount of air a person can forcefully and quickly exhale after taking a deep breath.
Time Frame
Baseline to Week 52
Secondary Outcome Measure Information:
Title
Time to Clinical Worsening
Description
Clinical worsening was monitored from randomization until 1 of the following criteria were met: death (all causes), hospitalization due to a respiratory indication, or 10% relative decline in % predicted FVC.
Time Frame
Baseline to Week 52
Title
Time to First Acute Exacerbation of IPF
Description
An exacerbation of IPF is defined as an acute, clinically significant, respiratory deterioration characterized by evidence of new widespread alveolar abnormality.
Time Frame
Baseline to Week 52
Title
Overall Survival at Week 52
Description
Vital status will be assessed for all subjects at Week 52, including those who discontinue the study prematurely or who withdraw consent.
Time Frame
Week 52
Title
Change in % Predicted FVC from Baseline to Week 52
Description
The FVC measurement indicates the amount of air a person can forcefully and quickly exhale after taking a deep breath. Percent predicted FVC is calculated based on factors such as ethnicity, sex, age, height, and weight.
Time Frame
Baseline to Week 52
Title
Change in K-BILD Questionnaire Score from Baseline to Week 52
Description
The K-BILD is a self-administered, 15-item questionnaire validated for patients with interstitial lung disease (ILD) consisting of 3 domains (breathlessness and activities, psychological, and chest symptoms).
Time Frame
Baseline to Week 52
Title
Change in DLCO from Baseline to Week 52
Description
The DLCO measurement measures how well oxygen moves from the lungs to the blood.
Time Frame
Baseline to Week 52

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subject gives voluntary informed consent to participate in the study. Subject is ≥40 years of age, inclusive, at the time of signing informed consent. The subject has a diagnosis of IPF based on the 2018 ATS/ERS/JRS/ALAT Clinical Practice Guideline (Raghu 2018) and confirmed by central review of high-resolution computed tomography (HRCT) (performed within the previous 12 months), and if available, surgical lung biopsy. FVC ≥45% predicted at Screening. Subjects on pirfenidone or nintedanib must be on a stable and optimized dose for ≥30 days prior to Baseline. Concomitant use of both pirfenidone and nintedanib is not permitted. Women of childbearing potential must be non-pregnant (as confirmed by a urine pregnancy test at Screening and Baseline) and non-lactating, and will abstain from intercourse (when it is in line with their preferred and usual lifestyle) or use 2 medically acceptable, highly effective forms of contraception for the duration of the study, and at least 30 days after discontinuing study drug. Males with a partner of childbearing potential must use a condom for the duration of treatment and for at least 48 hours after discontinuing study drug. In the opinion of the Investigator, the subject is able to communicate effectively with study personnel, and is considered reliable, willing, and likely to be cooperative with protocol requirements, including attending all study visits. Exclusion Criteria: Subject is pregnant or lactating. Subject has primary obstructive airway physiology: FEV1/FVC <0.70 at Screening. The subject has shown intolerance or significant lack of efficacy to a prostacyclin or prostacyclin analogue that resulted in discontinuation or inability to effectively titrate that therapy. The subject has received any PAH-approved therapy, including prostacyclin therapy (epoprostenol, treprostinil, iloprost, or beraprost; except for acute vasoreactivity testing), IP receptor agonists (selexipag), endothelin receptor antagonists, phosphodiesterase type 5 inhibitors (PDE5-Is), or soluble guanylate cyclase stimulators within 60 days prior to Baseline. As needed use of a PDE5-I for erectile dysfunction is permitted, provided no doses are taken within 48 hours of any study-related efficacy assessments. Use of any of the following medications: azathioprine (AZA), cyclosporine, mycophenolate mofetil, tacrolimus, oral corticosteroids (OCS) >20 mg/day or the combination of OCS+AZA+N-acetylcysteine within 30 days prior to Baseline; cyclophosphamide within 60 days prior to Baseline; or rituximab within 6 months prior to Baseline. The subject is receiving >10 L/min of oxygen supplementation by any mode of delivery at rest at Baseline. Exacerbation of IPF or active pulmonary or upper respiratory infection within 30 days prior to Baseline. Subjects must have completed any antibiotic or steroid regimens for treatment of the infection or acute exacerbation more than 30 days prior to Baseline to be eligible. If hospitalized for an acute exacerbation of IPF or a pulmonary or upper respiratory infection, subjects must have been discharged more than 90 days prior to Baseline to be eligible. Uncontrolled cardiac disease, defined as myocardial infarction within 6 months prior to Baseline or unstable angina within 30 days prior to Baseline. In the opinion of the Investigator, the subject has any condition that would interfere with the interpretation of study assessments or would impair study participation or cooperation. Use of any other investigational drug/device or participation in any investigational study in which the subject received a medical intervention (ie, procedure, device, medication/supplement) within 30 days prior to Screening. Subjects participating in non-interventional, observational, or registry studies are eligible. Life expectancy <6 months due to IPF or a concomitant illness. Acute pulmonary embolism within 90 days prior to Baseline.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
United Therapeutics Global Medical Information
Phone
919-485-8350
Email
clinicaltrials@unither.com
Facility Information:
Facility Name
The University of Alabama at Birmingham
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35233
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Melessia Wells
Phone
205-975-9332
Email
mrasheed@uabmc.edu
First Name & Middle Initial & Last Name & Degree
Tejaswini Kulkarni, MD
Facility Name
Jasper Summit Research, LLC
City
Jasper
State/Province
Alabama
ZIP/Postal Code
35501
Country
United States
Individual Site Status
Withdrawn
Facility Name
Arizona Pulmonary Specialists, Ltd.
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85012
Country
United States
Individual Site Status
Terminated
Facility Name
St. Joseph's Hospital and Medical Center - Norton Thoracic Institute
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85013
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gabrielle Ambrose
Phone
602-406-3825
Email
gabrielle.ambrose@commonspirit.org
First Name & Middle Initial & Last Name & Degree
Rajat Walia, MD
Facility Name
University of Arizona
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85724
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maria Ambrose
Phone
520-621-8149
Email
maeambrose@arizona.edu
First Name & Middle Initial & Last Name & Degree
Sachin Chaudhary, MD
Facility Name
UC San Diego Health
City
La Jolla
State/Province
California
ZIP/Postal Code
92037
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amber Martineau
Phone
619-471-0817
Email
ajm002@health.ucsd.edu
First Name & Middle Initial & Last Name & Degree
Gordon Yung, MD
Facility Name
David Geffen School of Medicine at UCLA
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Paul Lopez
Phone
310-794-8595
Email
plopez@mednet.ucla.edu
First Name & Middle Initial & Last Name & Degree
Samuel Weigt, MD
Facility Name
NewportNativeMD, Inc
City
Newport Beach
State/Province
California
ZIP/Postal Code
92663
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Grace Harvey
Phone
949-791-8599
Email
Grace@newportnativemd.com
First Name & Middle Initial & Last Name & Degree
Ryan Klein, MD
Facility Name
University of California, Irvine
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jordan Perkins
Phone
714-509-6579
Email
jperkin3@hs.uci.edu
First Name & Middle Initial & Last Name & Degree
Bassam Yaghmour, MD
Facility Name
Palmtree Clinical Research, Inc.
City
Palm Springs
State/Province
California
ZIP/Postal Code
92262
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Daniel Rangel
Phone
760-778-7799
Email
Drangel@palmtreeclinical.com
First Name & Middle Initial & Last Name & Degree
Ziad Tannous, MD
Facility Name
UC Davis Health Medical Center
City
Sacramento
State/Province
California
ZIP/Postal Code
95817
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sarah Natera
Phone
916-734-1820
Email
srnatera@ucdavis.edu
First Name & Middle Initial & Last Name & Degree
Namita Sood, MD
Facility Name
University of California - San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94143
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Darren Leong
Phone
415-353-2296
Email
Darren.Leong@ucsf.edu
First Name & Middle Initial & Last Name & Degree
Jeffrey Golden, MD
Facility Name
Stanford University Medical Center
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fareshta Khushzad
Phone
650-725-8083
Email
fkhush@stanford.edu
First Name & Middle Initial & Last Name & Degree
Rishi Raj, MD
Facility Name
National Jewish Health
City
Denver
State/Province
Colorado
ZIP/Postal Code
80206
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Faduma Ahmed
Phone
303-398-1285
Email
ahmedf@njhealth.org
First Name & Middle Initial & Last Name & Degree
Joshua Solomon, MD
Facility Name
Georgetown University Hospital
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20007
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amen Hamed
Phone
202-444-0895
Email
amen.m.hamed@gunet.georgetown.edu
First Name & Middle Initial & Last Name & Degree
Tunay Kuru, MD
Facility Name
St. Francis Sleep Allergy & Lung Institute
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33765
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amber Dunn
Phone
727-210-4606
Email
adunn@stfrancismed.com
First Name & Middle Initial & Last Name & Degree
Francis Averill, MD
Facility Name
University of Florida Health at Shands
City
Gainesville
State/Province
Florida
ZIP/Postal Code
32610
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rosie Kizza
Phone
352-273-7225
Email
rosie.kizza@medicine.ufl.edu
First Name & Middle Initial & Last Name & Degree
Ibrahim Faruqi, MD
Facility Name
Ascension St. Vincent's
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32204
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer McWilliams
Phone
904-308-5764
Email
Jennifer.Mcwilliams@ascension.org
First Name & Middle Initial & Last Name & Degree
Harish Bhaskar, MD
Facility Name
University of Florida
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32209
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kiley Kathleen
Phone
904-244-4694
Email
Kathleen.Kiley@jax.ufl.edu
First Name & Middle Initial & Last Name & Degree
Vandana Seeram, MD
Facility Name
Mayo Clinic Florida
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32224
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meenakshi Shukla
Phone
904-953-3811
Email
Becerrit.Indira@mayo.edu
First Name & Middle Initial & Last Name & Degree
Augustine Lee, MD
Facility Name
Pulmonary Disease Specialists, PA d/b/a PDS Research
City
Kissimmee
State/Province
Florida
ZIP/Postal Code
34741
Country
United States
Individual Site Status
Terminated
Facility Name
Central Florida Pulmonary Group, PA
City
Orlando
State/Province
Florida
ZIP/Postal Code
32803
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sharon Foust
Phone
407-841-1100
Ext
135
Email
sfoust@cfpulmonary.com
First Name & Middle Initial & Last Name & Degree
Syed Mobin, MD
Facility Name
Advanced Pulmonary Research Institute
City
Palm Beach
State/Province
Florida
ZIP/Postal Code
33470
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Isis Recarey
Phone
561-795-1022
Email
aprirnir@gmail.com
First Name & Middle Initial & Last Name & Degree
Neal Warshoff, MD
Facility Name
Coastal Pulmonary & Critical Care PLC
City
Saint Petersburg
State/Province
Florida
ZIP/Postal Code
33704
Country
United States
Individual Site Status
Terminated
Facility Name
University of South Florida Health
City
Tampa
State/Province
Florida
ZIP/Postal Code
33606
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brenda Farlow
Phone
813-844-8407
Email
bfarlow@tgh.org
First Name & Middle Initial & Last Name & Degree
Debabrata Bandyopadhyay, MD
Facility Name
Cleveland Clinic Florida
City
Weston
State/Province
Florida
ZIP/Postal Code
33331
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Delmy Zelaya
Phone
954-659-5885
Email
zelayad2@ccf.org
First Name & Middle Initial & Last Name & Degree
Jinesh Mehta, MD
Facility Name
Piedmont Healthcare Atlanta
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30309
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Olayinka Elemide
Phone
404-670-5361
Email
Olayinka.Elemide@piedmont.org
First Name & Middle Initial & Last Name & Degree
Amy Case, MD
Facility Name
Emory University Hospital
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30322
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mitzi Near
Phone
404-712-9603
Email
mnear@emory.edu
First Name & Middle Initial & Last Name & Degree
Srihari Veeraraghavan, MD
Facility Name
Northwestern Memorial Hospital
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aaron Gundersheimer
Phone
312-503-7475
Email
aaron.gundersheimer@northwestern.edu
First Name & Middle Initial & Last Name & Degree
Jane Dematte D'Amico, MD
Facility Name
Rush University Medical Center Outpatient Pulmonary Clinic
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60612
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joyce Brown
Phone
312-942-6771
Email
Joyce_Brown@rush.edu
First Name & Middle Initial & Last Name & Degree
Xiaoping Wu, MD
Facility Name
University of Illinois at Chicago
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60612
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hannah Carlson
Phone
312-355-5895
Email
hrc@uic.edu
First Name & Middle Initial & Last Name & Degree
Dustin Fraidenburg, MD
Facility Name
Loyola University Medical Center
City
Maywood
State/Province
Illinois
ZIP/Postal Code
60153
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adriana Martinez
Phone
708-216-2057
Email
amartinez59@luc.edu
First Name & Middle Initial & Last Name & Degree
Daniel Dilling, MD
Facility Name
Community Health Network
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46250
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brenda Newman
Phone
317-621-7724
Email
bnewman@ecommunity.com
First Name & Middle Initial & Last Name & Degree
Sasikanth Adigopula, MD
Facility Name
The University of Kansas Medical Center
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carime Ward
Phone
913-588-1850
Email
Cward8@kumc.edu
First Name & Middle Initial & Last Name & Degree
Sahil Pandya, MD
Facility Name
Norton Pulmonary Specialists
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kimberly Robinson
Phone
502-587-8000
Email
kimberly.robinson@nortonhealthcare.org
First Name & Middle Initial & Last Name & Degree
J. Wesley McConnell, MD
Facility Name
University of Louisville
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Belica Graf
Phone
502-852-5841
Email
belica.graf@louisville.edu
First Name & Middle Initial & Last Name & Degree
Mohammed Saad, MD
Facility Name
Louisville Pulmonary Care,PLLC
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40207
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wendi Haller
Phone
502-899-7377
Email
wendihaller@gmail.com
First Name & Middle Initial & Last Name & Degree
Harold Haller, MD
Facility Name
LSU Health Sciences Center New Orleans
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70112
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Paula Lauto
Phone
504-568-3452
Email
plauto@lsuhsc.edu
First Name & Middle Initial & Last Name & Degree
Amita Krishnan, MD
Facility Name
Tulane University Medical Center
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70112
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sandy Ditta
Phone
504-988-4040
Email
sditta@tulane.edu
First Name & Middle Initial & Last Name & Degree
Joseph Lasky, MD
Facility Name
LSU Health Science Center Shreveport
City
Shreveport
State/Province
Louisiana
ZIP/Postal Code
71103
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nathan Glassy
Phone
318-675-8308
Email
nathaniel.glassy@lsuhs.edu
First Name & Middle Initial & Last Name & Degree
Prangthip Charoenpong, MD
Facility Name
Johns Hopkins Asthma & Allergy Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21224
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sarah Collins
Phone
410-550-2062
Email
shirsh1@jhmi.edu
First Name & Middle Initial & Last Name & Degree
Sonye Danoff, MD
Facility Name
Adventist Healthcare White Oak Medical CEnter
City
Silver Spring
State/Province
Maryland
ZIP/Postal Code
20904
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer Hernandez
Phone
240-637-5024
Email
jhernandez1@adventisthealthcare.com
First Name & Middle Initial & Last Name & Degree
Jonathan B Cohen, MD
Facility Name
Tufts Medical Center
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02111
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Daniel Strick
Phone
617-636-6304
Email
dstrick@tuftsmedicalcenter.org
First Name & Middle Initial & Last Name & Degree
Nicholas Hill, MD
Facility Name
Brigham and Women's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maeda Anthony
Phone
617-525-9292
Email
amaeda2@bwh.harvard.edu
First Name & Middle Initial & Last Name & Degree
Gary Hunninghake, MD
Facility Name
University of Michigan Int Med Pulmonary and critical care
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Linda Briggs
Phone
734-232-5844
Email
briggsl@med.umich.edu
First Name & Middle Initial & Last Name & Degree
Elizabeth Belloli, MD
Facility Name
Henry Ford Hospital
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48202
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sherae Hereford
Phone
313-916-1254
Email
sherefo3@hfhs.org
First Name & Middle Initial & Last Name & Degree
Krishna Thavarajah, MD
Facility Name
University of Minnesota
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55455
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mandi DeGrote
Phone
612-626-7609
Email
carl1032@umn.edu
First Name & Middle Initial & Last Name & Degree
Hyun Kim, MD
Facility Name
Mayo Clinic
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55902
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shannon Daley
Phone
507-293-0637
Email
daley.shannon@mayo.edu
First Name & Middle Initial & Last Name & Degree
Teng Moua, MD
Facility Name
University of Mississippi Medical Center
City
Jackson
State/Province
Mississippi
ZIP/Postal Code
39216
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shelby Lee
Phone
601-496-7815
Email
selee@umc.edu
First Name & Middle Initial & Last Name & Degree
Andrew Wilhelm, MD
Facility Name
The Lung Research Center
City
Chesterfield
State/Province
Missouri
ZIP/Postal Code
63017
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna Shipp
Phone
314-682-3653
Email
anna.shipp@stlukes-stl.com
First Name & Middle Initial & Last Name & Degree
Neil Ettinger, MD
Facility Name
Saint Luke's Hospital of Kansas City
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64111
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rosann Gans
Phone
816-932-6122
Email
rgans@saint-lukes.org
First Name & Middle Initial & Last Name & Degree
Mark Yagan, MD
Facility Name
Washington University School of Medicine
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hannah Perkins
Phone
314-362-9919
Email
hperkins@wustl.edu
First Name & Middle Initial & Last Name & Degree
Tonya Russell, MD
Facility Name
J&L Research, LLC
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
72032
Country
United States
Individual Site Status
Withdrawn
Facility Name
Creighton University Clinical Research Office
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68124
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Theresa Ramelb
Phone
402-280-4146
Email
theresaramelb@creighton.edu
First Name & Middle Initial & Last Name & Degree
Lee Morrow, MD
Facility Name
University of New Mexico Health Sciences Center
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87106
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Guillermo Valdivia
Phone
505-272-9992
Email
GValdivia@salud.unm.edu
Email
gvaldivia@salud.unm.edu
First Name & Middle Initial & Last Name & Degree
Nour Ass'ad, MD
Facility Name
Montefiore Medical Center
City
Bronx
State/Province
New York
ZIP/Postal Code
10467
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jane Wilson
Phone
718-920-7916
Email
jwilson4@montefiore.org
First Name & Middle Initial & Last Name & Degree
Ali Mansour, MD
Facility Name
Northwell Health
City
New Hyde Park
State/Province
New York
ZIP/Postal Code
11040
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sara Khan
Phone
516-465-5437
Email
skhan109@northwell.edu
First Name & Middle Initial & Last Name & Degree
Arunabh Talwar, MD
Facility Name
University of Rochester Medical center
City
Rochester
State/Province
New York
ZIP/Postal Code
14642
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Geoffrey Rice
Phone
585-276-7355
Email
Geoffrey_Rice@URMC.Rochester.edu
First Name & Middle Initial & Last Name & Degree
Mathew R Kottmann, MD
Facility Name
PulmonIx, LLC
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27403
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Reba Morris
Phone
336-522-8870
Email
reba.morris@pulmonix.com
First Name & Middle Initial & Last Name & Degree
Murali Ramaswamy, MD
Facility Name
East Carolina University and Leo Jenkins Cancer Center
City
Greenville
State/Province
North Carolina
ZIP/Postal Code
27834
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shravya Dharambhat
Phone
252-744-1116
Email
dharambhats22@ecu.edu
First Name & Middle Initial & Last Name & Degree
Shehabaldin M Alqalyoobi, MD
Facility Name
Pinehurst Medical Clinic, Inc.
City
Pinehurst
State/Province
North Carolina
ZIP/Postal Code
28374
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Becky Kennedy
Phone
919-708-1524
Email
rkennedy@pinehurstmedical.com
First Name & Middle Initial & Last Name & Degree
Michael Pritchett, DO
Facility Name
Southeastern Research Center
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lauren Miller
Phone
336-659-8414
Email
lmiller@southeasternresearchcenter.com
First Name & Middle Initial & Last Name & Degree
Benjamin Bregman, MD
Facility Name
University of Cincinnati
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45267
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emillie Hoh
Phone
513-558-0337
Email
Hohek@ucmail.uc.edu
First Name & Middle Initial & Last Name & Degree
Nishant Gupta, MD
Facility Name
Cleveland Clinic
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ron Wehrmann
Phone
216-445-0574
Email
wehrmar@ccf.org
First Name & Middle Initial & Last Name & Degree
Joseph Parambil, MD
Facility Name
The Ohio State University Wexner Medical Center - Martha Morehouse Medical Pavilion
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43221
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ben Hood
Phone
614-293-3351
Email
benjamin.hood2@osumc.edu
First Name & Middle Initial & Last Name & Degree
Nitin Bhatt, MD
Facility Name
University of Oklahoma Health Sciences Center
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maria Mason
Phone
405-271-8001
Ext
2
Email
maria-l-mason@ouhsc.edu
First Name & Middle Initial & Last Name & Degree
Jad Kebbe, MD
Facility Name
The Oregon Clinic, PC
City
Portland
State/Province
Oregon
ZIP/Postal Code
97220
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meg Day
Phone
503-963-3182
Email
mday@orclinic.com
First Name & Middle Initial & Last Name & Degree
Granthem Farr, MD
Facility Name
Penn State Milton S. Hershey Medical Center/Penn State College of Medicine
City
Hershey
State/Province
Pennsylvania
ZIP/Postal Code
17033
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Timothy Sheehan
Phone
717-531-2925
Email
tsheehan@pennstatehealth.psu.edu
First Name & Middle Initial & Last Name & Degree
Rebecca Bascom, MD
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sarah Alam
Phone
215-662-6280
Email
sarah.alam@pennmedicine.upenn.edu
First Name & Middle Initial & Last Name & Degree
Michaela Restivo Anderson, MD
Facility Name
Thoams Jefferson,Hospital University
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ramya Talluri
Phone
215-955-9181
Email
RamyaPriya.Talluri@jefferson.edu
First Name & Middle Initial & Last Name & Degree
Gautam George, MD
Facility Name
Temple Lung Center
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19140
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kim Selwood
Phone
215-707-2291
Email
Kim.Selwood@tuhs.temple.ed
First Name & Middle Initial & Last Name & Degree
Parth Rali, MD
Facility Name
Medical University of South Carolina
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29425
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Max Lento
Phone
843-792-9697
Email
lento@musc.edu
First Name & Middle Initial & Last Name & Degree
Rachana Krishna, MD
Facility Name
Prisma Health Midlands
City
Columbia
State/Province
South Carolina
ZIP/Postal Code
29203
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Keera Mckenna
Phone
803-434-7703
Email
Keera.Mckenna2@PrismaHealth.org
First Name & Middle Initial & Last Name & Degree
Abhi Gupta, MD
Facility Name
Clinical Research of Rock Hill
City
Rock Hill
State/Province
South Carolina
ZIP/Postal Code
29732
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Caroline Reynolds
Phone
803-251-9502
Email
creynolds@cresrh.com
First Name & Middle Initial & Last Name & Degree
Michael Denenberg, MD
Facility Name
Clinical Trials Center of Middle Tennessee
City
Franklin
State/Province
Tennessee
ZIP/Postal Code
37067
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessica Wallan
Phone
615-205-8350
Email
jwallan@ctcmidtn.com
First Name & Middle Initial & Last Name & Degree
Aaron Milstone, MD
Facility Name
Statecare Pulmonary Consultants
City
Knoxville
State/Province
Tennessee
ZIP/Postal Code
37919
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Whitney Henderson
Phone
865-934-2676
Email
whitney.henderson@biomed-research.com
First Name & Middle Initial & Last Name & Degree
Eric Weaver, MD
Facility Name
Vanderbilt University Medical Center
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37204
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jim Del Greco
Phone
615-322-0476
Email
james.del.greco@vumc.org
First Name & Middle Initial & Last Name & Degree
Justin Hewlett, MD
Facility Name
Baylor University Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75246
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sharon Brown
Phone
214-820-0338
Email
Sharon.Brown1@BSWHealth.org
First Name & Middle Initial & Last Name & Degree
Yosafe Wakwaya, MD
Facility Name
Univrsity of Texas Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390-8550
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nighat Sultana
Phone
214-645-6493
Email
Nighat.Sultana@UTSouthwestern.edu
First Name & Middle Initial & Last Name & Degree
Traci Adams, MD
Facility Name
Premier Pulmonary Critical Care and Sleep Medicine
City
Denison
State/Province
Texas
ZIP/Postal Code
75020
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Muhammad Butt
Phone
903-465-5012
Email
mo@premierpsm.com
First Name & Middle Initial & Last Name & Degree
Sanober Kable, MD
Facility Name
Baylor Clinic-Baylor College of Medicine
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Valeria Ortega Apraez
Phone
713-798-7351
Email
Valeria.OrtegaApraez@bcm.edu
First Name & Middle Initial & Last Name & Degree
Ivan Rosas, MD
Facility Name
The University of Texas Health Science Center at Houston
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yeraldin Morales
Phone
713-486-6859
Email
yeraldin.morales@uth.tmc.edu
First Name & Middle Initial & Last Name & Degree
Rahat Hussain, MD
Facility Name
A & A Research Consultants, LLC
City
McAllen
State/Province
Texas
ZIP/Postal Code
78503
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Karla Asian Rojas
Phone
972-802-1512
Email
aaresearchconsultants@gmail.com
First Name & Middle Initial & Last Name & Degree
Alfredo Arauco Brown, MD
Facility Name
Metroplex Pulmonary and Sleep Center PA
City
McKinney
State/Province
Texas
ZIP/Postal Code
75069
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rupa Krishna
Phone
972-954-6002
Email
rkrishna@mpsleepcenter.com
First Name & Middle Initial & Last Name & Degree
Shahrukh Kureishy, MD
Facility Name
Renovatio Clinical Consultants, LLC
City
The Woodlands
State/Province
Texas
ZIP/Postal Code
77380
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Intermountain Medical Center
City
Murray
State/Province
Utah
ZIP/Postal Code
84107
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joshua Jeppson
Phone
801-507-4727
Email
Joshua.Jeppson@imail.org
First Name & Middle Initial & Last Name & Degree
Peter Crossno, MD
Facility Name
University of Utah Health
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84108
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Cassie Larsen
Phone
801-581-5811
Email
cassie.larsen@hsc.utah.edu
First Name & Middle Initial & Last Name & Degree
Mary Beth Scholand, MD
Facility Name
University of Virginia Health System
City
Charlottesville
State/Province
Virginia
ZIP/Postal Code
22903
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yousef Althulth
Phone
434-924-0749
Email
KPQ5SK@hscmail.mcc.virginia.edu
First Name & Middle Initial & Last Name & Degree
Hannah Mannem, MD
Facility Name
Inova Fairfax Hospital
City
Falls Church
State/Province
Virginia
ZIP/Postal Code
22042
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Priscila Dauphin
Phone
703-776-7128
Email
priscila.dauphin@inova.org
First Name & Middle Initial & Last Name & Degree
Christopher King, MD
Facility Name
Pulmonary Associates of Richmond, Inc.
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23230
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Betsy Daniel
Phone
804-591-3533
Email
bdaniel@paraccess.com
First Name & Middle Initial & Last Name & Degree
Shilpa Johri, MD
Facility Name
University of Wisconsin School of Medicine and Public health
City
Madison
State/Province
Wisconsin
ZIP/Postal Code
53792
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shelby Perket
Phone
608-890-3662
Email
srperket@clinicaltrials.wisc.edu
First Name & Middle Initial & Last Name & Degree
Stephen J Halliday, MD
Facility Name
Medical College of Wisconsin
City
Milwaukee
State/Province
Wisconsin
ZIP/Postal Code
53226
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alyssa Ruediger
Phone
414-955-6875
Email
aruediger@mcw.edu
First Name & Middle Initial & Last Name & Degree
Mark Barash, DO
Facility Name
Institut Universitaire de Cardiologie et de Pneumologie de Quebec-Universite
City
Quebec
ZIP/Postal Code
G1V 4G5
Country
Cameroon
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luce Bouffard
Phone
418-656-4701
Email
luce.bouffard@criucpq.ulaval.ca
First Name & Middle Initial & Last Name & Degree
Steeve Provencher, MD

12. IPD Sharing Statement

Learn more about this trial

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

We'll reach out to this number within 24 hrs